138 related articles for article (PubMed ID: 36942165)
1. Longitudinal Trends of Hospitalizations for Giant Cell Arteritis: A 21-Year Longitudinal National Population-Based Study.
Hino C; Edigin E; Aihie O; Odion J; Eseaton P; Okpujie V; Onobraigho P; Omoike E; Manadan A; Hojjati M
Cureus; 2023 Feb; 15(2):e35038. PubMed ID: 36942165
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal trends of systemic lupus erythematous hospitalizations in the United States: a two-decade population-based study.
Edigin E; Trang A; Ojemolon PE; Eseaton PO; Shaka H; Kichloo A; Bazuaye EM; Okobia NO; Okobia RI; Sandhu V; Manadan A
Clin Rheumatol; 2023 Mar; 42(3):695-701. PubMed ID: 36287285
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
4. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
5. Race and Gender on the Mortality of Giant Cell Arteritis in Hospitalized Patients: A 15-Year National Inpatient Study.
Idowu AB; Khandwala P; Tan IJ
Cureus; 2023 Sep; 15(9):e46165. PubMed ID: 37905266
[TBL] [Abstract][Full Text] [Related]
6. Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.
Unizony S; Menendez ME; Rastalsky N; Stone JH
Rheumatology (Oxford); 2015 Aug; 54(8):1360-8. PubMed ID: 25667435
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Emergency Department Visits by Patients With Giant Cell Arteritis: A National Population-Based Study.
Hino C; Edigin E; Aihie O; Eseaton P; Okpujie V; Onobraigho P; Omoike E; Hojjati M
Cureus; 2023 Feb; 15(2):e35121. PubMed ID: 36945258
[TBL] [Abstract][Full Text] [Related]
8. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
9. The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?
John Michet C; Crowson CS; Achenbach SJ; Matteson EL
J Rheumatol; 2015 Nov; 42(11):2071-4. PubMed ID: 26233503
[TBL] [Abstract][Full Text] [Related]
10. Trajectory of Healthcare Resource Utilization in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Turkiewicz A; Stamatis P; Turesson C; Englund M; Kiadaliri A
J Rheumatol; 2021 Aug; 48(8):1307-1313. PubMed ID: 33649063
[TBL] [Abstract][Full Text] [Related]
11. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.
Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ
J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.
Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C
Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007
[TBL] [Abstract][Full Text] [Related]
13. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
14. The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients.
Chung SH; Morcos MB; Pollock PS; Ng B
Clin Rheumatol; 2021 Jul; 40(7):2829-2833. PubMed ID: 33417014
[TBL] [Abstract][Full Text] [Related]
15. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
[TBL] [Abstract][Full Text] [Related]
16. The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.
Aviña-Zubieta JA; Bhole VM; Amiri N; Sayre EC; Choi HK
Ann Rheum Dis; 2016 Jan; 75(1):148-54. PubMed ID: 25265937
[TBL] [Abstract][Full Text] [Related]
17. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
18. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.
Kermani TA; Warrington KJ; Crowson CS; Ytterberg SR; Hunder GG; Gabriel SE; Matteson EL
Ann Rheum Dis; 2013 Dec; 72(12):1989-94. PubMed ID: 23253927
[TBL] [Abstract][Full Text] [Related]
19. Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment.
Therkildsen P; de Thurah A; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
Semin Arthritis Rheum; 2021 Apr; 51(2):360-366. PubMed ID: 33601192
[TBL] [Abstract][Full Text] [Related]
20. Is There an Association between Herpetic Infections and Giant Cell Arteritis? A Population-Based Study.
Lee DH; Iovieno A; Sheldon CA
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
